South Korean company Dong-A ST wins FDA approval for Stelara biosimilar
South Korea-based Dong-A ST has received a US Food and Drug Administration (FDA) approval for Imuldosa (ustekinumab-srlf/DMB-3115), a biosimilar that…
News
FDA AdCom votes in favour of Stealth’s Barth syndrome drug
Roche wins first-line approval for PI3K inhibitor combo in breast cancer
XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Booster Therapeutics to develop proteasome activator medicines
KeyBioscience and Eli Lilly extend partnership for obesity treatments
CPHI Europe: Targeting supply chain bottlenecks key for cell and gene therapies
